EU Approval Nod Possible For Novartis, Gilead/Galapagos, and Janssen
CHMP Marketing Opinions Are Due On Alpelisib, Filgotinib, Ebola Vaccines
The May meeting of the European Medicines Agency’s drug evaluation committee, the CHMP, is under way. Decisions are due on whether eight marketing approval applications should be approved for marketing in the EU.
